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Individual age estimation can be applied to criminal, legal, and anthropological
investigations. DNA methylation has been established as the biomarker of choice for
age prediction, since it was observed that specific CpG positions in the genome
show systematic changes during an individual’s lifetime, with progressive increases or
decreases in methylation levels. Subsequently, several forensic age prediction models
have been reported, providing average age prediction error ranges of ±3–4 years,
using a broad spectrum of technologies and underlying statistical analyses. DNA
methylation assessment is not categorical but quantitative. Therefore, the detection
platform used plays a pivotal role, since quantitative and semi-quantitative technologies
could potentially result in differences in detected DNA methylation levels. In the present
study, we analyzed as a shared sample pool, 84 blood-based DNA controls ranging
from 18 to 99 years old using four different technologies: EpiTYPER R©, pyrosequencing,
MiSeq, and SNaPshotTM. The DNA methylation levels detected for CpG sites from
ELOVL2, FHL2, and MIR29B2 with each system were compared. A restricted three
CpG-site age prediction model was rebuilt for each system, as well as for a combination
of technologies, based on previous training datasets, and age predictions were
calculated accordingly for all the samples detected with the previous technologies.
While the DNA methylation patterns and subsequent age predictions from EpiTYPER R©,
pyrosequencing, and MiSeq systems are largely comparable for the CpG sites studied,
SNaPshotTM gives bigger differences reflected in higher predictive errors. However,
these differences can be reduced by applying a z-score data transformation.
Keywords: epigenetics, DNA methylation, age estimation, EpiTYPER R©, pyrosequencing, MiSeq, SNaPshotTM
INTRODUCTION
DNA methylation is the most widely studied epigenetic mark in the human genome (Jones, 2012).
Methylation, which is the incorporation of a methyl group at cytosine-guanine dinucleotide motifs,
has been shown to be highly correlated with the human aging process (Bocklandt et al., 2011;
Hannum et al., 2013; Horvath, 2013; Johansson et al., 2013), and as a consequence, is currently
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considered the most accurate age prediction biomarker. The
estimation of an individual’s epigenetic age in this way is
useful in several areas. From a forensic point of view, the
ability to accurately predict the chronological age of the donor
of a biological sample can provide relevant information in
order to guide police investigation in cases where no suspects
or matches in the DNA database are found (Freire-Aradas
et al., 2017). From a clinical point of view, biological age
estimation may help to determine the life expectancy of
the individual (Horvath and Raj, 2018). In order to infer
the chronological age, several age prediction models have
been developed based on data generated using different DNA
methylation technologies, including EpiTYPER R© (Xu et al., 2015;
Freire-Aradas et al., 2016; Zubakov et al., 2016), pyrosequencing
(Weidner et al., 2014; Bekaert et al., 2015; Zbieć-Piekarska
et al., 2015), massively parallel sequencing (MPS) (Naue et al.,
2017; Vidaki et al., 2017; Aliferi et al., 2018) and SNaPshotTM
(Lee et al., 2015; Hong et al., 2017; Jung et al., 2019)
systems. As DNA methylation is quantitative in nature, potential
differences in DNA methylation levels can be detected by
each technology. For this reason, systematic comparisons of
methylation detection technologies using a common set of
controls become necessary.
A shared characteristic of these aforementioned DNA
methylation technologies is their reliance on bisulfite conversion
of the analyzed samples. Bisulfite conversion is a pretreatment
of the genomic DNA that coverts all the unmethylated cytosines
to uracil, which after PCR, are replaced with thymine; while the
methylated CpGs remain unaltered; converting a methylation
difference into a sequence difference (Frommer et al., 1992;
Clark et al., 1994). Two main limitations are related to the
bisulfite conversion process. First, it degrades the DNA and
consequently, a larger amount of genomic DNA than usual
must be used. Second, it reduces DNA sequence variability,
diminishing the multiplexing capacity of the technologies used.
In spite of these constraints, the high quality of the corresponding
DNA methylation measurements favors their use in current
forensic applications.
EpiTYPER R© detects and quantifies DNA methylation
based on MALDI-TOF mass spectrometry (Ehrich et al.,
2006). EpiTYPER R© analyses the cleaved fragments with
varied molecular weights depending on the methylation
status around each fragment, which are measured and the
corresponding DNA methylation levels ascertained. Although
single-nucleotide CpG positions are measured, some CpGs
very close to each other are detected as a block providing an
average methylation value for a set of two to three CpG sites.
Pyrosequencing is considered the gold standard method for
measuring targeted DNA methylation (Lehmann and Tost,
2015). It is an accurate quantitative sequencing-by-synthesis
method based on luminescence, following an enzymatic
cascade that uses the production of light after pyrophosphate
release when a nucleotide is incorporated onto a growing
DNA strand. Despite its high accuracy, it is difficult to analyze
multiple markers simultaneously, hindering its use in forensic
casework where the quality/quantity of DNA samples is
usually restricted. MPS (also called next generation sequencing
or NGS) is a high-throughput technology that sequences
multiple target-specific regions in parallel and quantitatively
detects DNA methylation levels by the ratio of sequence read
coverage amongst targets (Richards et al., 2018). For forensic
casework, two main companies provide the equipment necessary
to run DNA methylation analysis with MPS technology:
Illumina using the MiSeq system, and Thermo Fisher using
the Ion S5 detector. MiSeq technology uses sequencing-by-
synthesis where a fluorescently labeled reversible terminator
is imaged as each dNTP is added, and then cleaved to allow
incorporation of the next base. Ion Torrent technology is based
on semiconductor sequencing, i.e., each time a nucleotide is
incorporated in the growing DNA strand, a proton is released
and the consequent variation in pH is measured as a change
in electrical conductivity. MPS appears to be a highly accurate
technology for DNA methylation analysis while allowing
for multiplexing. Nevertheless, the high cost associated with
both the equipment and reagents is a constraining factor for
some forensic laboratories that require a more cost-effective
technology such as single base extension (SBE) that can be easily
incorporated into well-established capillary electrophoresis
systems. SBE (also called minisequencing or SNaPshotTM) is a
semi-quantitative technology based on fluorescence (Fondevila
et al., 2017). It consists of the annealing of an unlabeled
oligonucleotide that matches the sequence immediately adjacent
to the target nucleotide site. The subsequent incorporation
of a single complementary fluorescently labeled terminator
ddNTP produces a sequence strand extended by one nucleotide.
While the multiplex capacity of this method is an advantage,
the different fluorescence intensities between each of the dyes
linked to the ddNTPs used, can potentially bias the methylation
values detected.
Up until now, age prediction models have been developed
based on data collected using one technology, i.e., if an age
prediction model is built based on pyrosequencing data, the
subsequent test samples are also analyzed by pyrosequencing,
and so on, since some loss of accuracy was previously reported
for inter-technology data exchange (Vidaki et al., 2017; Aliferi
et al., 2018). This represents a constraint, since each technology
requires the re-building of the prediction model with new age
reference sample sets. We aimed to compare DNA methylation
data from different technologies in order to explore if platform-
independent models might be useful for forensic age prediction.
The study of Hong et al. (2019) has already introduced this
concept by developing a platform-independent model for MPS
and SNaPshotTM in saliva samples. In the present study, we cover
a further inter-technology comparison for DNA methylation
based on MPS and SNaPshotTM technologies, but adding
methods based on EpiTYPER R© and pyrosequencing. A total
of 84 common control DNAs from blood between 18 and
99 years old were analyzed using the four different technologies
for three CpG sites in ELOVL2, FHL2, and MIR29B2 genes.
The corresponding DNA methylation levels were compared,
and several age prediction models were subsequently tested
in the common samples detected with either the same
or different technologies to the system used to build the
training set.
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MATERIALS AND METHODS
DNA Samples and DNA Methylation Data
A total of 84 blood sample-derived DNA extracts were obtained
from healthy European volunteers ranging in age from 18 to
99 years. The samples were used as the testing set (referenced as
common controls). All samples were obtained from the ‘Carlos
III’ Spanish National DNA Bank, University of Salamanca,
and ethical approval was granted from the ethics committee
of investigation in Galicia, Spain (CAEI: 2013/543). All DNA
samples were quantified by Qubit R© dsDNA High Sensitivity
(HS) Assay Kit (Thermo Fisher) and subsequently normalized
to 10 ng/µL. Additionally, DNA methylation data for a total of
1130 European blood samples ranging in age from 2 to 104 years
were selected from previous studies that used EpiTYPER R©
(N = 725) (Freire-Aradas et al., 2016), pyrosequencing (N = 293)
(Zbieć-Piekarska et al., 2015), and MiSeq (N = 112) (Aliferi
et al., 2018) for building the training sets. Moreover, a total
of 105 European blood samples ranging in age from 18 to
75 years were analyzed using SNaPshotTM in order to build the
corresponding training set.
CpG Sites Selection and DNA
Methylation Detection
A total of three age-correlated genes were used for comparative
purposes: ELOVL2, FHL2, and MIR29B2 – loci that have been
commonly included in age prediction models analyzing blood-
based DNA samples (Garagnani et al., 2012; Bekaert et al.,
2015; Zbieć-Piekarska et al., 2015; Freire-Aradas et al., 2016;
Park et al., 2016; Zubakov et al., 2016; Hong et al., 2019;
Jung et al., 2019). In the present study, these three genes were
analyzed by three independent laboratories using four DNA
methylation technologies: EpiTYPER R©, pyrosequencing, MiSeq,
and SNaPshotTM. Table 1 describes the overlap between CpG
sites and DNA methylation technologies used in this study. All
CpGs are single CpG sites, with the exception of MIR29B2_C1
that consisted of a cluster of three CpG sites, since EpiTYPER R©
could not give individual results for each site. Therefore, an
average of the three corresponding CpG sites was used when
comparing the corresponding DNA methylation values with
pyrosequencing or MiSeq for this case. Regarding the overlap
in Table 1; ELOVL2, FHL2, and MIR29B2_C1 were used for
comparing EpiTYPER R©, pyrosequencing, and MiSeq; whereas
SNaPshotTM comparisons were made in a separate analysis.
In this case, ELOVL2, FHL2, and MIR29B2_C2 were used for
comparing EpiTYPER R© and MiSeq systems with the SNaPshotTM
system. Analyses were extended to more than one CpG per gene
in the case of MIR29B2 due to a lack of complete overlap between
technologies. ELOVL2 and FHL2 were represented by the same
CpG site in all analyses. All four DNA methylation technologies
require a pretreatment with sodium bisulfite. Three bisulfite kits
were used according to the methylation detection technology that
will be described below. Supplementary Table S1 summarizes
additional variable factors between technologies.
Agena Bioscience EpiTYPER R© DNA
Methylation Analysis
The Agena Bioscience EpiTYPER R© system (San Diego, CA,
United States) used PCR amplicons of 362 base pairs (bp) for
ELOVL2, 191 bp for FHL2 and 344 bp for MIR29B2. Samples
analyzed using EpiTYPER R© were bisulfite converted using the
EZ DNA MethylationTM Kit (Zymo Research) using 300 ng
of genomic DNA. A detailed description of the EpiTYPER R©
workflow has been previously reported (Freire-Aradas et al.,
2016, 2018). Methylation data were obtained using EpiTYPER R©
software v.1.2.22 (Agena Bioscience).
Pyrosequencing
Pyrosequencing of the PCR amplicons used for this technology
were 308 bp for ELOVL2, 167 bp for FHL2 and 146 bp for
MIR29B2. Bisulfite conversion was performed using the Qiagen
96-well bisulfite conversion kit (Qiagen, Hilden, Germany)
using 1 µg of genomic DNA. Specific procedures for the
pyrosequencing workflow were previously outlined (Zbieć-
Piekarska et al., 2015). This technology was performed using
a PyroMark vacuum prep workstation and a PyroMark Q24
instrument (Qiagen), following the manufacturer’s guidelines.
The data were automatically analyzed using PyroMark analysis
software (Qiagen, Hilden, Germany).
The MiSeq System
Massively parallel sequencing-based detection of methylated
DNA was performed using the MiSeq system (Illumina).
Samples detected using MiSeq were bisulfite converted using
the MethylEdge R© Bisulfite Conversion System (Promega
Corporation, Fitchburg, WI, United States) using 50 ng of
genomic DNA. Detailed information regarding the workflow
can be found in Aliferi et al. (2018). The amplicon sizes used
were 308 bp for ELOVL2, 165 bp for FHL2 and 210 bp for
TABLE 1 | Overlap between CpG sites from the target genes ELOVL2, FHL2, and MIR29B2 in the four evaluated DNA methylation technologies: (A) EpiTYPER R©, (B)
Pyrosequencing, (C) MiSeq, and (D) SNaPshotTM.
Gene CpG_ID GRCh38 position (A) EpiT (B) Pyros (C) MiSeq (D) SNaP
ELOVL2 cg21572722 chr6:11044661
√ √ √ √
FHL2 cg06639320 chr2:105399282





All CpGs are single sites, except MIR29B2_C1 that is a cluster of three CpG sites. The corresponding DNA methylation values for MIR29B2_C1 were calculated as the
average of the three CpG sites for each technology.
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MIR29B2. Analysis of the FASTQ files was conducted with
the Burrows-Wheeler Aligner, Sequence Alignment/Map
and Genome Analysis Toolkit software following guidelines
from Aliferi et al. (2018).
Single Base Extension (SBE)
Single base extension was performed using the SNaPshotTM
Multiplex Kit (Thermo Fisher) in replicate analyses. PCR
amplicon sizes were 111 bp for ELOVL2, 108 bp for FHL2 and
49 bp for MIR29B2. Samples for SNaPshotTM analyses were
bisulfite converted using the MethylEdge R© Bisulfite Conversion
System (Promega Corporation, Fitchburg, WI, United States,
assay B) using 100 ng of genomic DNA. Specific multiplex
protocol details are summarized in Supplementary Table S2.
Methylation values were calculated based on the peak height
ratio [methylated signal/(methylated signal + unmethylated
signal)] obtained with GeneMapperID v3.2.1 software, measuring
RFU values (relative fluorescence units). The average of the
DNA methylation values between replicates were used for
SNaPshotTM analyses.
Statistical Analyses
Comparisons of DNA methylation measurement methods were
performed using Bland-Altman plots using the BlandAltmanLeh
R package (Lehnert, 2015). These plots represent the difference
between paired measures for the same variable against the
corresponding mean (Giavarina, 2015). The upper and lower
limits of agreement (LoA) were calculated as the mean of
the differences between two measurements ±1.96 times the
standard deviation (SD) between them, accordingly, in order
to include 95% of the differences within them (Bland and
Altman, 1999). A limit of acceptance, or threshold of ±0.098
has been established a priori (±1.96.SD, SD = 0.05). Normality
was tested using a Shapiro–Wilk normality test. Uniformity, i.e.,
absence of tendency for DNA methylation differences between
methods, was checked using regression analysis (p-value for
the fitted regression line). Differences in DNA methylation
levels between technologies were also explored using analysis of
variance (ANOVA).
All age prediction modeling was based on quantile regression
(QR) (Freire-Aradas et al., 2016; Smeers et al., 2018). The
original datasets for the training sets were composed of a higher
number of samples and CpG sites than the data required for the
reported analyses; specifically: N = 725, 18–104 years, 7 CpGs;
N = 293, 2–75 years, 5 CpGs and N = 112, 11–93 years, 12
CpGs measured by EpiTYPER R©, pyrosequencing, and MiSeq,
respectively (Zbieć-Piekarska et al., 2015; Freire-Aradas et al.,
2016; Aliferi et al., 2018). Therefore, model re-building was
performed in order to harmonize age distribution and sample
size, as well as to cover only the three CpG sites under study.
The age range was restricted to 18–75 years old for all the
training sets. Age range restriction directly led to N = 100 for
MiSeq. In the case of EpiTYPER R© and pyrosequencing, besides
age range restriction, random selection of a maximum of two
individuals per year-of-age led to N = 116 for EpiTYPER R© and
N = 106 for pyrosequencing. Quantiles 0.1 and 0.9 (q10 and q90)
were used for the development of the multivariate QR model
using the quantreg R package (Koenker et al., 2019). Random
cleavage of the input data for the QR model validation was done
using the cvTools R package (Alfons, 2015). Validation of the QR
model was performed using k−fold cross−validation (k = 10).
The corresponding predictive accuracy was measured with the
following performance metrics: median absolute prediction error
(MAE); root-mean-square error (RMSE); percent of correct
predicted samples with a prediction error of±5 years (%CP± 5)
and percent of correct predicted samples within the prediction
intervals (%CP ± PI). Predicted versus chronological age was
plotted using the ggplot2 R package (Wickham and Chang,
2019). Z-score transformation was performed scaling the DNA
methylation levels to the corresponding mean and SD. All
calculations were performed using R software v3.4.2.
RESULTS
Intra-Technology Variation
Intra-technology variation was assessed analyzing two replicates
for the semi-quantitative technology used in the present study,
i.e., SNaPshotTM. Previous work on EpiTYPER R© (Freire-Aradas
et al., 2016), pyrosequencing (Zbieć-Piekarska et al., 2015),
and MiSeq (Aliferi et al., 2018) showed absence of technical
variation for these DNA methylation technologies and therefore,
the corresponding common controls were analyzed using a
single replicate.
Supplementary Figure S1 depicts the DNA methylation
levels against the chronological age for ELOVL2, FHL2, and
MIR29B2_C2 for both replicates for the 84 common controls. An
absence of statistically significant differences between replicates
(p-value > 0.01) allowed the study to use the average DNA
methylation levels for SNaPshotTM analyses.
Comparison of DNA Methylation Levels
for EpiTYPER R© vs. Pyrosequencing vs.
MiSeq vs. SNaPshotTM
DNA methylation analysis for ELOVL2, FHL2, and MIR29B2 for
the 84 common controls was performed using EpiTYPER R©,
pyrosequencing, MiSeq, and SNaPshotTM technologies.
The corresponding DNA methylation data (β-values) is
shown in Supplementary Table S3. Figure 1 shows the DNA
methylation levels against the chronological age for ELOVL2,
FHL2, MIR29B2_C1, and MIR29B2_C2 for the overlapping
technologies, while Table 2 describes the corresponding
ANOVA test. The major differences were displayed by ELOVL2
and MIR29B2_C2 detected using SNaPshotTM technology.
Additionally, moderate statistically significant differences were
also found for MIR29B2_C1 comparing EpiTYPER R© vs. MiSeq
(p-value: 0.00303).
Figure 2 depicts the corresponding paired Bland-Altman
plots using the previous DNA methylation values. The central
dotted gray line represents the mean of the differences; while
the discontinuous gray lines represent the upper and lower LoA,
including the 95% of differences between one measurement and
the other. The red line indicates the theoretical ‘no differences
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FIGURE 1 | DNA methylation levels compared with chronological age in ELOVL2, FHL2, MIR29B2_C1, and MIR29B2C_C2 for 84 common controls (18–99 years
old) detected using EpiTYPER R© (orange), pyrosequencing (dark magenta), MiSeq (light blue), and SNaPshotTM (green).
between methods’. Bland-Altman differences presented a normal
distribution for ELOVL2 and FHL2 for all pairwise comparisons
with the exception of those compared to SNaPshotTM technology
(Shapiro–Wilk normality test). Regarding MIR29B2_C1, an
absence of normality for EpiTYPER R© vs. pyrosequencing and
for pyrosequencing vs. MiSeq was observed (p-value < 0.01).
In MIR29B2_C2, an absence of normality was found for
MiSeq vs. SNaPshotTM. Uniformity was found for both
ELOVL2 and FHL2, but not for MIR29B2. Absence of
uniformity was detected for MIR29B2_C1 for EpiTYPER R©
vs. pyrosequencing (Figure 2M) and EpiTYPER R© vs. MiSeq
(Figure 2N), as well as for MIR29B2_C2 for EpiTYPER R©




EpiTYPER R© vs. pyrosequencing 0.066
EpiTYPER R© vs. MiSeq 0.447
Pyrosequencing vs. MiSeq 0.012
EpiTYPER R© vs. SNaPshotTM 10−13
Pyrosequencing vs. SNaPshotTM 2 × 10−16
MiSeq vs. SNaPshotTM 6.1 × 10−11
FHL2
EpiTYPER R© vs. pyrosequencing 0.636
EpiTYPER R© vs. MiSeq 0.0113
Pyrosequencing vs. MiSeq 0.0369
EpiTYPER R© vs. SNaPshotTM 0.309
Pyrosequencing vs. SNaPshotTM 0.128
MiSeq vs. SNaPshotTM 0.000257
MIR292B_C1
EpiTYPER R© vs. pyrosequencing 0.476
EpiTYPER R© vs. MiSeq 0.00303
Pyrosequencing vs. MiSeq 0.0111
MIR292B_C2
EpiTYPER R© vs. MiSeq 0.631
EpiTYPER R© vs. SNaPshotTM 7.63 × 10−5
MiSeq vs. SNaPshotTM 0.000313
p-values marked in bold are statistically significant (p-value < 0.01).
vs. SNaPshotTM (Figure 2P) and for MiSeq vs. SNaPshotTM
(Figure 2R) (p-value < 0.01). In particular, Figure 2M shows
a tendency to overestimate DNA methylation levels with
EpiTYPER R© vs. pyrosequencing at high values, while DNA
methylation levels between 0.5 and 0.2 are underestimated
using this technology for MIR29B2_C1 (Figure 1). Regarding
MIR29B2_C2, when comparing EpiTYPER R© vs. SNaPshotTM
(Figure 2P) and for MiSeq vs. SNaPshotTM (Figure 2R),
similar DNA methylation values are observed at high values
that gradually diverge when DNA methylation values between
0.6 and 0.3 are detected. An additional bias was observed
for MIR29B2_C1 for pyrosequencing vs. MiSeq (Figure 2O),
that is explained by an underestimation by pyrosequencing
or an overestimation by MiSeq of the DNA methylation
levels (Figure 1).
If excluding SNaPshotTM comparisons, the mean of the
differences between the DNA methylation levels detected
using different technologies for ELOVL2 and FHL2 for all
pairwise comparisons was quite close to zero (average: ±0.03).
SNaPshotTM comparisons for FHL2 also detected reduced DNA
methylation differences between technologies (average: +0.03).
However, higher deviations were detected for ELOVL2 (average:
−0.12) due to an overestimation of the DNA methylation levels
using SNaPshotTM compared to the other three technologies
(Figure 1). This explains a raised value for the lower LoA for
ELOVL2 when including SNaPshotTM analyses (average lower
LoA: −0.22) – with values that exceed the established threshold
(±0.098). Regarding MIR29B2 (C1 or C2), for analyses not
including SNaPshotTM data, the mean of the differences was
reduced (average: −0.04), as the comparison with SNaPshotTM
significantly increased these differences (average:−0.085).
Age Prediction for DNA Methylation Data
From EpiTYPER R©, Pyrosequencing, and
MiSeq Using ELOVL2, FHL2, and
MIR29B2_C1
The three CpG sites (ELOVL2, FHL2, and MIR29B2_C1) were
used for age estimation of the 84 common controls using the
reference training sets based on EpiTYPER R©, pyrosequencing,
and MiSeq. Figure 3 shows the predicted age vs. chronological
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FIGURE 2 | Bland-Altman plots comparing pairs of four DNA methylation technologies: EpiTYPER R©, pyrosequencing, MiSeq, and SNaPshotTM in ELOVL2, FHL2,
MIR29B2_C1, and MIR29B2_C2 for 84 common controls (18–99 years old). The plots represent the differences between paired methods (x–y) against the mean of
both paired methods [(x + y)/2] for the following pairs: (A,G,M) EpiTYPER R© (x) vs. pyrosequencing (y), (B,H,N) EpiTYPER R© (x) vs. MiSeq (y), (C,I,O) pyrosequencing
(x) vs. MiSeq (y), (D,J,P) EpiTYPER R© (x) vs. SNaPshotTM (y), (E,K,Q) pyrosequencing (x) vs. SNaPshotTM (y), and (F,L,R) MiSeq (x) vs. SNaPshotTM (y). The
central dotted gray line represents the mean of the differences; while the discontinuous gray lines represent the upper and lower LoA. The red line indicates the
theoretical no differences between methods.
age for both training and testing sets, and Table 3, the
corresponding performance metrics.
All four training sets – EpiTYPER R©, pyrosequencing, MiSeq
and the combined training set derived from the combination
of the three technologies (Figures 3A,E,I,M, respectively) –
provided errors lower than±5 years (MAE: from±3.14 to±4.11)
and correct prediction rates higher than 70% (%CP ± PI: from
74.02 to 77.92%). However, for the aim of the present study,
an intra-training set comparison rather than an inter-training
set comparison was performed, i.e., we compared testing data
from the three DNA methylation technologies analyzed using a
uniform training set.
From the data modeled using the EpiTYPER R© training
set, no statistically significant differences were found for the
prediction errors shown by the common controls analyzed
with EpiTYPER R©, pyrosequencing or MiSeq (p-value > 0.01).
However, a general underestimation of age for common controls
older than 60 years was detected in pyrosequencing (Figure 3C).
Samples analyzed with MiSeq provided the best prediction rates
(%CP± PI: 75%).
The prediction model using the pyrosequencing training set
gave no statistically significant differences for the prediction
errors in the technologies analyzing common controls
(p-value > 0.01). In this case, both pyrosequencing and
MiSeq underestimated common control age for the whole age
range (Figures 3G,H). In spite of this, samples detected with
MiSeq provided the best prediction rates (%CP± PI: 84.52%).
The prediction model using the MiSeq training set gave no
statistically significant differences for the prediction errors in the
technologies analyzing common controls (p-value > 0.01). As
with the EpiTYPER R© training set, a global underestimation of
age for common controls older than 60 years was detected in
pyrosequencing (Figure 3K). The best prediction rates were again
provided by MiSeq detection (%CP± PI: 85.71%).
In view of the similarities found for prediction errors
and the accurate predictions displayed for common controls,
all data from the previous training sets, e.g., EpiTYPER R©,
pyrosequencing, and MiSeq, were combined in order to create a
new enlarged platform-independent training set. As before, no
statistically significant differences were found for the common
control prediction errors in any technology used (p-value > 0.01).
In common with individual training sets, common controls
older than 60 years old were underestimated by pyrosequencing
(Figure 3O) and samples detected with MiSeq gave the best
prediction rates (%CP± PI: 84.52%).
Age Prediction for DNA Methylation Data
From EpiTYPER R©, MiSeq, and
SNaPshotTM Using ELOVL2, FHL2, and
MIR29B2_C2
In a subsequent analysis using a different set of CpG sites
(ELOVL2, FHL2, and MIR29B2_C2), age prediction was assessed
and results plotted in Figure 4, showing the predicted age versus
the chronological age using common controls detected with
EpiTYPER R©, MiSeq, and SNaPshotTM. Table 4 summarizes the
corresponding performance metrics.
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FIGURE 3 | Predicted versus chronological age using four training sets from three DNA methylation technologies using 3-CpG-site models (ELOVL2, FHL2, and
MIR29B2_C1) for the 84 common controls (18–99 years old). (A) EpiTYPER R© training set, (B–D) EpiTYPER R©, pyrosequencing, and MiSeq testing sets analyzed with
the EpiTYPER R© training set, (E) pyrosequencing training set, (F–H) EpiTYPER R©, pyrosequencing, and MiSeq testing sets analyzed with the pyrosequencing training
set; (I) MiSeq training set, (J–L) EpiTYPER R©, pyrosequencing, and MiSeq testing sets analyzed with the MiSeq training set; (M) Combined training set, (N–P)
EpiTYPER R©, pyrosequencing, and MiSeq test sets analyzed with the combined training set. The continuous gray line represents perfect correlation. The
discontinuous gray lines represent the prediction intervals.
All four training sets – EpiTYPER R©, MiSeq, SNaPshotTM and
the combined training set derived from the combination of the
previous three technologies (Figures 4A,E,I,M, respectively) –
provided errors lower than ±4 years (MAE: from ±2.98 to
±3.83) and correct prediction rates higher than 75% (%CP ± PI:
from 76.59 to 79.12%). Figures 4B.1–4P.1 represent the
corresponding testing sets.
For the prediction model using the EpiTYPER R© training
set, statistically significant differences were found for the
prediction errors in the common controls (p-value < 0.01). These
differences were explained by a higher error rate in SNaPshotTM
analysis of common controls (MAE: ±4.71), which was reflected
in a decreased correct prediction rate (%CP ± PI: 44.05%).
The best predictions were obtained in EpiTYPER R© analysis
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TABLE 3 | Age predictive performance metrics for the training and test sets based
on the analysis of three CpG sites (ELOVL2, FHL2, and MIR29B2_C1) using
EpiTYPER R©, pyrosequencing and MiSeq DNA methylation technologies, as well
as a combination of all three technologies (Combined).
MAE
Technology Group (years) RMSE %CP ± 5 %CP ± PI
EpiTYPER R© Training (N = 116) ±3.29 5.15 70.53% 74.02%
EpiTYPER R© Testing (N = 84) ±3.46 5.99 67.07% 70.73%
Pyrosequencing Testing (N = 84) ±2.79 6.48 69.51% 73.17%
MiSeq Testing (N = 84) ±3.37 5.74 69.05% 75%
Pyrosequencing Training (N = 106) ±3.14 5.9 67.55% 76.73%
EpiTYPER R© Testing (N = 84) ±4.03 6.36 62.2% 78.05%
Pyrosequencing Testing (N = 84) ±3.6 6.79 64.63% 81.71%
MiSeq Testing (N = 84) ±3.11 5.72 72.62% 84.52%
MiSeq Training (N = 100) ±4.11 6.33 57% 76%
EpiTYPER R© Testing (N = 84) ±3.14 6.08 68.29% 80.49%
Pyrosequencing Testing (N = 84) ±2.52 6.65 69.51% 85.37%
MiSeq Testing (N = 84) ±2.69 5.55 76.19% 85.71%
Combined Training (N = 322) ±3.73 5.86 63.99% 77.92%
EpiTYPER R© Testing (N = 84) ±3.05 5.93 71.95% 80.49%
Pyrosequencing Testing (N = 84) ±2.57 6.62 74.39% 80.49%
MiSeq Testing (N = 84) ±2.49 5.52 77.38% 84.52%
MAE: median absolute prediction error, RMSE: root-mean-square error, %CP:
percent correct prediction, PI: prediction intervals.
of common controls (%CP ± PI: 75.61%). Although similar
errors to those of the initial MiSeq analyses of the training set
were found here (MAE: ± 3.31), the correct prediction rate
was reduced (%CP ± PI: 58.33%) due to an overestimation of
common controls younger than 45 years old (Figure 4C.1).
In spite of not detecting statistically significant differences
between the common controls modeled using the MiSeq training
set, the correct prediction rate for the SNaPshotTM samples was
reduced (%CP ± PI: 51.19%). The best predictions were shown
by the MiSeq data (%CP± PI: 85.71%).
Data modeled using the SNaPshotTM training set presented
the highest statistically significant differences (p-value = 2e−16).
Test samples analyzed using either EpiTYPER R© or MiSeq
displayed high errors (MAE: ±14 and ±11.59, respectively), as
well as minimum correct prediction rates (%CP ± PI: 31.71 and
47.62%, respectively).
In spite of these differences, a model using all the previous
training sets was combined into a single platform-independent
training set (Figure 4M). This combined model harmonized
the data derived from all the technologies where prediction
errors had no statistically significant differences (p-value > 0.01).
Accordingly, similar correct prediction rates were obtained for
all common controls detected using EpiTYPER R©, MiSeq, and
SNaPshotTM (82.93, 78.57, and 77.38%, respectively).
Due to the differences encountered for SNaPshotTM
analyses when compared to EpiTYPER R© and MiSeq, a
z-score transformation was applied in order to check if
the corresponding predictions could be improved by data
scaling (Table 5). The application of a z-score transformation
removed the previously encountered statistical differences. The
EpiTYPER R© and MiSeq test sets were markedly improved when
modeled with the SNaPshotTM training set (Figures 4J.2,K.2,
%CP ± PI: 78.05 and 75% in comparison to the previous
31.71 and 47.62%, respectively). Similarly, the SNaPshotTM test
set substantially improved when modeled with EpiTYPER R©
and MiSeq training sets (Figures 4D.2,H.2, %CP ± PI: 77.38
and 85.71% in comparison to previous values of 44.05 and
51.19%, respectively).
DISCUSSION
Correlation has been proposed as a statistical technique in
order to compare technologies (Hong et al., 2019). However,
this parameter evaluates the relationship or association between
one variable and another, not their differences. In order to
compare the differences between two measurement methods
in our study, Bland-Altman analysis was applied (Giavarina,
2015). Bland-Altman analysis describes the degree of agreement
between two quantitative technologies for the same variable
(Bland and Altman, 1999) – in our case, between four DNA
methylation detection methods. With this analysis, 95% of the
differences between two methods are plotted within the LoA.
It is important to consider that the maximum accepted LoA
should be established before the analysis, according to analytical
or biological criteria. Since some intra-technical variance was
already accepted for DNA methylation (SD ≤ 0.05 for replicates)
(Freire-Aradas et al., 2016), inter-technical deviation based on
the Bland-Altman’s LoA and previous intra-technical variance
was explored in the present study (±1.96 SD = ±0.098). In
addition to the LoA, it is also recommended that the differences
between technologies are normally distributed, although not
essential. However, uniformity is required before data can be used
interchangeably.
Four DNA methylation technologies were compared
using four CpG sites from ELOVL2, FHL2, and MIR29B2.
Normality was analyzed for all the pairwise comparisons.
Differences were normally distributed for ELOVL2 and
FHL2 for all pairwise comparisons, except for ELOVL2 in
EpiTYPER R©/pyrosequencing/MiSeq vs. SNaPshotTM, and
MIR29B2 presented partial normal distribution. However,
absence of normality can be handled in our study since subjects
were not chosen randomly, but to give a wide distribution of
the factor measured. The critical parameter that is required
to exchange data among technologies without affecting the
outcome is uniformity (Bland and Altman, 1999). Uniformity
can be observed as the absence of a tendency for the differences
to change between methods, i.e., the extent of the differences is
uniformly maintained independently of the magnitude of the
variable. In our study, uniformity is measured as the variance
in the differences across the range of DNA methylation levels,
and this should be maintained. The ELOVL2 and FHL2 CpG
sites in the present work displayed complete uniformity for all
comparisons made. The same cannot be said for MIR29B2. This
marker had an evident tendency to show changes in differences
in several comparisons (Figures 2M,N,P,R; p-value < 0.1). Some
of them are explained by similar DNA methylation detection at
high DNA methylation levels that gradually diverge – increasing
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FIGURE 4 | Predicted versus chronological age using four training sets from three DNA methylation technologies and a 3-CpG-site model (ELOVL2, FHL2, and
MIR29B2_C2) for the 84 common controls (18–99 years old). (A) EpiTYPER R© training set, (B–D) EpiTYPER R©, MiSeq, and SNaPshotTM testing sets analyzed with
the EpiTYPER R© training set, (E) MiSeq training set, (F–H) EpiTYPER R©, MiSeq, and SNaPshotTM testing sets analyzed with the MiSeq training set, (I) SNaPshotTM
training set, (J–L) EpiTYPER R©, MiSeq and SNaPshotTM testing sets analyzed with the SNaPshotTM training set, (M) Combined training set, (N–P) EpiTYPER R©,
MiSeq and SNaPshotTM testing sets analyzed with the combined training set. Panels (B.1–P.1) correspond to untransformed data, while panels (B.2–P.2)
correspond to z-score transformed data. The continuous gray line represents the perfect correlation. The discontinuous gray lines represent the prediction intervals.
the value of the differences when DNA methylation levels
between 0.6 and 0.3 are detected (Figure 1, MIR29B2_C2).
However, MIR29B2_C1 for MiSeq vs. pyrosequencing behaves
in the opposite way; i.e., bigger differences are found at high
DNA methylation levels, that progressively decrease when DNA
methylation values at about 0.3 are detected (Figure 1).
With regard to the DNA methylation levels, the highest levels
of similarity were displayed by the quantitative technologies
of EpiTYPER R©, pyrosequencing and MiSeq, especially for
ELOVL2 and FHL2. Nevertheless, some differences among
these technologies were found in MIR29B2, although not
statistically significant (p-value > 0.01) (Figures 2M–R) as
they slightly exceeded the LoA from the established threshold
of ±0.098 (average lower LoA: −0.15). However, it can be
concluded from our findings that when differences are uniformly
within an established LoA, then methodologies can be used
interchangeably (Bland and Altman, 1999). In order to test if
the differences observed in the DNA methylation values are
critical or not, the corresponding age predictions were performed
using four re-configured age prediction models constructed
using DNA methylation data detected with EpiTYPER R© (Freire-
Aradas et al., 2016), pyrosequencing (Zbieć-Piekarska et al.,
2015), and MiSeq (Aliferi et al., 2018). In this way, despite
differences encountered in MIR29B2, the prediction accuracy
of the corresponding age prediction models when comparing
EpiTYPER R©, pyrosequencing, and MiSeq was not affected
(Figure 3 and Table 3). Nevertheless, it is important to note
the underestimation of predicted age using pyrosequencing
(Figures 3C,G,K,O) to test common controls older than 60 years.
In addition to this, previous replication experiments had
indicated reproducibility for DNA methylation levels detected
using EpiTYPER R© (Bocklandt et al., 2011), MPS (Pabinger
et al., 2016), and pyrosequencing (Bocklandt et al., 2011)
compared with data from Infinium BeadChip arrays. This is
an important factor to consider, since discovery studies are
predominantly based on Infinium arrays, and identified age-
associated CpG sites are subsequently validated using targeted
DNA methylation technologies.
Different patterns are obtained when SNaPshotTM analyses are
included. SNaPshotTM is a semi-quantitative method and this is
reflected in the differences detected for estimated methylation
levels. Due to a lack of overlap among the MIR29B2 CpG
sites between technologies, an independent comparison was
performed in order to include SNaPshotTM analyses. The
major differences were found for ELOVL2 and MIR29B2_C2
when comparing either EpiTYPER R© or MiSeq with SNaPshotTM
(Figures 2D–F,P–R). The main difference between both markers
is the lack of uniformity for MIR29B2_C2, with a tendency
to generate more differences when detecting DNA methylation
levels between 0.6 and 0.3 (Figure 1). However, differences for
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TABLE 4 | Age predictive performance metrics for the training and test sets based
on the analysis of three CpG sites (ELOVL2, FHL2, and MIR29B2_C2) using
EpiTYPER R©, MiSeq, and SNaPshotTM DNA methylation technologies, as well as
a combination of all three technologies (Combined).
MAE
Technology Group (years) RMSE %CP ± 5 %CP ± PI
EpiTYPER R© Training (N = 116) ±3.56 4.88 72.2% 76.59%
EpiTYPER R© Testing (N = 84) ±3.05 5.32 71.95% 75.61%
MiSeq Testing (N = 84) ±3.31 5.77 64.29% 58.33%
SNaPshotTM Testing (N = 84) ±4.71 7.78 53.57% 44.05%
MiSeq Training (N = 100) ±3.6 6 65% 77%
EpiTYPER R© Testing (N = 84) ±3.22 5.73 69.51% 74.39%
MiSeq Testing (N = 84) ±2.81 5.83 77.38% 85.71%
SNaPshotTM Testing (N = 84) ±3.12 7.96 67.86% 51.19%
SNaPshotTM Training (N = 105) ±2.98 4.43 76.09% 77%
EpiTYPER R© Testing (N = 84) ±14 14.93 4.88% 31.71%
MiSeq Testing (N = 84) ±11.59 12.49 14.29% 47.62%
SNaPshotTM Testing (N = 84) ±3.4 8.2 58.33% 60.71%
Combined Training (N = 321) ±3.83 5.56 64.45% 79.12%
EpiTYPER R© Testing (N = 84) ±2.9 5.27 68.29% 82.93%
MiSeq Testing (N = 84) ±3.03 5.52 73.81% 78.57%
SNaPshotTM Testing (N = 84) ±3.8 7.43 63.1% 77.38%
MAE: median absolute prediction error, RMSE: root-mean-square error, %CP:
percent correct prediction, PI: prediction intervals.
TABLE 5 | Age predictive performance metrics based on a z-score transformation
for the training and test sets analyzing three CpG sites (ELOVL2, FHL2, and
MIR29B2_C2) and using EpiTYPER R©, MiSeq, and SNaPshotTM DNA methylation
technologies, plus the combination of all three technologies (Combined).
MAE
Technology Group (years) RMSE %CP ± 5 %CP ± PI
EpiTYPER R© Training (N = 116) ±3.56 4.88 72.2% 76.59%
EpiTYPER R© Testing (N = 84) ±3.12 5.08 75.61% 80.49%
MiSeq Testing (N = 84) ±3.03 5.41 75% 80.95%
SNaPshotTM Testing (N = 84) ±3 7.09 70.24% 77.38%
MiSeq Training (N = 100) ±3.6 6 65% 77%
EpiTYPER R© Testing (N = 84) ±3.03 5.4 70.24% 90.24%
MiSeq Testing (N = 84) ±3.65 5.75 63.1% 88.1%
SNaPshotTM Testing (N = 84) ±3.04 7.35 76.09% 85.71%
SNaPshotTM Training (N = 105) ±2.98 4.43 76.09% 77%
EpiTYPER R© Testing (N = 84) ±3.41 6.15 70.73% 78.05%
MiSeq Testing (N = 84) ±3.89 6.61 66.67% 75%
SNaPshotTM Testing (N = 84) ±3.48 7.81 71.43% 77.38%
Combined Training (N = 321) ±3.83 5.56 64.45% 79.12%
EpiTYPER R© Testing (N = 84) ±3.39 5.49 69.51% 85.37%
MiSeq Testing (N = 84) ±3.66 6.09 64.29% 80.95%
SNaPshotTM Testing (N = 84) ±3.5 7.67 65.48% 82.14%
MAE: median absolute prediction error, RMSE: root-mean-square error, %CP:
percent correct prediction, PI: prediction intervals.
ELOVL2, although present, are almost proportional between
methods (Figure 1). On the other hand, SNaPshotTM analysis
of FHL2 provided more similarities when compared with
EpiTYPER R© or MiSeq (mean of the differences:+0.02 and+0.06,
respectively). Differences encountered for SNaPshotTM could be
explained by differences in the intensity of the fluorochromes;
as previously reported by Hong et al. (2019). In spite of the
differences in ELOVL2 and MIR29B2_C2; it is important to
note that all three markers, including FHL2, were genotyped
using CT dyes and detected using an ABI3130. The CT dyes
used in SNaPshotTM are characterized by more closely matched
intensities in terms of fluorescence, and theoretically should
provide unbiased DNA methylation values, more similar to those
obtained using quantitative technologies than sites detected with
the AG SNaPshotTM dyes. Our results agree this assumption
only for FHL2, so additional factors are likely to be affecting
the results for ELOVL2 and MIR29B2_C2. The effect of such
differences is reflected in the age prediction accuracies (Table 4).
Either using the EpiTYPER R© or MiSeq training set, with the
worst predictions obtained for data analyzed using SNaPshotTM.
In view of these results, SNaPshotTM data cannot be used with
prediction models based on EpiTYPER R© or MiSeq technology.
However, it has been observed that if expanding the training
set to data from the three technologies, i.e., EpiTYPER R©, MiSeq,
and SNaPshotTM (combined training set), SNaPshotTM common
controls are correctly predicted at a similar rate to those detected
with EpiTYPER R© or MiSeq.
Although the training sets used in the prediction models from
the different DNA methylation technologies were harmonized
in terms of sample size, age distribution and the underlying
statistical model, factors potentially affecting technical variation
such as bisulfite conversion, DNA input, amplicon length or PCR
cycles should be taken into account (Supplementary Table S1).
One of the main factors affecting methylation results is the
efficiency of bisulfite conversion. The acid pH and high
temperatures accompanying this molecular process lead to
DNA fragmentation. It has been observed that different DNA
degradation rates can be encountered if using different bisulfite
conversion kits (Kint et al., 2018). Since fragmentation usually
leads to sequences smaller than 500 bp (Grunau et al., 2001), a
reduced amplification of longer amplicons could occur, although
the exact effects remain unknown. Differences in DNA input
could also affect results, although this should be linked to the
manufacturer’s recommendations as well as to the levels of
technical optimization achieved for each methodology. Variation
in DNA methylation levels could also be explained by biological
variation. Although in order to minimize this effect, common test
samples were represented by a single individual per year (18–
99 years old), biological variation cannot be discounted since
differences in white blood cell composition could alter DNA
methylation levels.
CONCLUDING REMARKS
To the best of our knowledge, this is the first study covering
the broadest possible comparison between DNA methylation
technologies currently applied to forensic age prediction.
Interchangeability of methylation data was found to be a suitable
strategy when differences in the DNA methylation levels from
different technologies do not exceed the uniformity threshold
established by this study of ±0.098 (±1.96.SD, SD = 0.05), and
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maintain this uniformity across the range of DNA methylation
values detected. If the differences slightly exceed the threshold,
it should be confirmed that these variations are not relevant for
age estimation. Although the CpG sites for ELOVL2, FHL2, and
MIR292B covered by the present study provide high accuracy
for age prediction for most of the comparisons performed,
in MIR292B the LoA is exceeded, and a lack of uniformity
is consistently observed. Therefore, DNA methylation data for
MIR292B should not be used independently of the technology
applied. These deviations could be explained by internal technical
problems, which we have observed for this gene (additional
methylation studies with publications in preparation). In
ELOVL2 and FHL2, similar patterns of DNA methylation for
EpiTYPER R©, pyrosequencing, and MiSeq were observed, and
subsequently data from these techniques can be used in platform-
independent age prediction models. However, our results are
linked to specific CpG positions – so no general extrapolations
can be assumed. If additional CpG sites from ELOVL2 and FHL2
are considered for inclusion in technology-free age prediction
models, the necessary validation tests should be made.
SNaPshotTM is a semi-quantitative technology based on
fluorescence using dyes with different signal intensities. This
introduces a bias in the DNA methylation values detected that
explains the differences found for ELOVL2 and MIR292B_C2
in SNaPshotTM compared with EpiTYPER R© or MiSeq,
which subsequently decrease the accuracy of corresponding
age predictions.
If differences are encountered between technologies; two
viable corrective measures could be applied, as proposed by
previous studies: (a) a z-score transformation in order to solve
batch effects (Feng et al., 2018) or; (b) the addition of an extra
covariate in the model indicating the type of technology used,
then introducing a correction for the method (Hong et al., 2019).
When a z-score transformation was tested in the present study
it markedly improved the results when SNaPshotTM data was
included in the analyses. If applying a platform-independent
model, there is a risk of losing age prediction accuracy if the
underlying sample size does not match the sample size of the
original age prediction model. Further work to increase the
number of samples tested among technologies will be necessary
to detect if prediction accuracies are affected by different sample
sizes. On the other hand, a re-analysis of the corresponding
training set using the technology of interest would be also be a
viable approach.
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